Skip to main content

Market Overview

44 Biggest Movers From Yesterday

Share:

Gainers

  • American Electric Technologies, Inc (NASDAQ: AETI) shares surged 126.35 percent to close at $1.675 on Monday after the company’s M&I Electric business announced a $14 million project with a leading Engineering, Procurement and Construction firm.
  • Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) shares gained 47.86 percent to close at $38.31 after the company reported updated interim Phase 1 clinical study results with DCC-2618 at the ASCO Annual Meeting.
  • Anavex Life Sciences Corp. (NASDAQ: AVXL) gained 31.71 percent to close at $3.78.
  • LiveXLive Media, Inc. (OTC: LIVX) rose 24.94 percent to close at $5.56.
  • Genomic Health, Inc. (NASDAQ: GHDX) shares rose 23.07 percent to close at $48.84 after the company disclosed that the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, successfully defined the benefit of chemotherapy in early-stage breast cancer patients with Oncotype DX Breast Recurrence Score® results of 11 to 25.
  • Highpower International Inc (NASDAQ: HPJ) shares rose 18.26 percent to close at $3.40 on Monday.
  • Renmin Tianli Group, Inc. (NASDAQ: ABAC) gained 17.51 percent to close at $2.55.
  • BIO-key International, Inc. (NASDAQ: BKYI) rose 17.04 percent to close at $2.61. BIO-key International disclosed that it has completed conversion of all outstanding preferred stock into common stock at a conversion price of $3.60 per share.
  • Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) rose 15.87 percent to close at $23.00.
  • Companhia Siderúrgica Nacional (NYSE: SID) climbed 14.98 percent to close at $2.38 on Monday.
  • ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) shares rose 14.92 percent to close at $9.78.
  • ProQR Therapeutics N.V. (NASDAQ: PRQR) climbed 13.91 percent to close at $6.55.
  • Sogou Inc. (NYSE: SOGO) gained 13.22 percent to close at $10.88 on Monday.
  • Evolus, Inc. (NASDAQ: EOLS) gained 11.77 percent to close at $30.49.
  • Arcturus Therapeutics Ltd. (NASDAQ: ARCT) shares rose 11.55 percent to close at $6.28 on Monday.
  • CSS Industries, Inc. (NYSE: CSS) rose 11.19 percent to close at $17.99. DA Davidson upgraded CSS Industries from Neutral to Buy.
  • Denali Therapeutics Inc. (NASDAQ: DNLI) gained 10.4 percent to close at $20.80.
  • Immunomedics, Inc. (NASDAQ: IMMU) shares rose 10.26 percent to close at $25.04. Clovis Oncology and Immunomedics reported a planned clinical collaboration to study combination therapies in metastatic triple-negative breast and urothelial cancers.
  • Petróleo Brasileiro S.A. - Petrobras (NYSE: PBRA) shares rose 9.7 percent to close at $9.39.

 

Losers

  • Nektar Therapeutics (NASDAQ: NKTR) shares tumbled 41.82 percent to close at $52.57 on Monday. Nektar and Bristol-Myers Squibb reported preliminary data for NKTR-214 in combination with opdivo for patients with Stage IV metastatic melanoma, renal cell carcinoma, and urothelial cancers.
  • Jounce Therapeutics, Inc. (NASDAQ: JNCE) dropped 33.48 percent to close at $7.47 after the company presented preliminary data from its ongoing Phase 1/2 ICONIC trial of JTX-2011 in patients with advanced solid tumors.
  • Kandi Technologies Group, Inc. (NASDAQ: KNDI) shares fell 29.36 percent to close at $3.85. The company announced that it was acquiring Sportsman Country for $10 million in restricted shares.
  • Mersana Therapeutics, Inc. (NASDAQ: MRSN) slipped 23 percent to close at $15.94 after the company presented interim dose-escalation data on XMT-1522 in select cancers at the ASCO 2018.
  • Daqo New Energy Corp. (NYSE: DQ) shares declined 20.71 percent to close at $41.80 on Monday after dropping 8.57 percent on Friday.
  • Vaxart, Inc. (NASDAQ: VXRT) fell 18.32 percent to close at $4.28 as the company disclosed that its Phase 2 trial of teslexivir did not meet its primary endpoint.
  • AC Immune SA (NASDAQ: ACIU) dropped 18.27 percent to close at $8.320.
  • CytomX Therapeutics, Inc. (NASDAQ: CTMX) declined 16.26 percent to close at $21.38.
  • Amtech Systems, Inc. (NASDAQ: ASYS) fell 16.13 percent to close at $8.32 on Monday.
  • Aduro BioTech, Inc. (NASDAQ: ADRO) shares dropped 15.38 percent to close at $7.15.
  • RF Industries, Ltd. (NASDAQ: RFIL) shares slipped 14.79 percent to close at $6.05 on Monday.
  • Gevo, Inc. (NASDAQ: GEVO) shares fell 14.58 percent to close at $4.10 on Monday.
  • Canadian Solar Inc. (NASDAQ: CSIQ) shares dropped 13.86 percent to close at $13.515.
  • Obalon Therapeutics, Inc. (NASDAQ: OBLN) shares dipped 13.04 percent to close at $2.20.
  • Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares tumbled 12.29 percent to close at $11.56.
  • Zymeworks Inc. (NYSE: ZYME) fell 12.21 percent to close at $19.19 on Monday.
  • Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) dropped 12.02 percent to close at $7.76
  • G1 Therapeutics, Inc. (NASDAQ: GTHX) shares fell 10.16 percent to close at $39.17 after the company presented Phase 1b data on G1T38 in combination with faslodex for treatment of breast cancer at the ASCO 2018.
  • PPDAI Group Inc. (NYSE: PPDF) shares declined 9.75 percent to close at $6.94 on Monday.
  • Blueprint Medicines Corporation (NASDAQ: BPMC) shares dropped 9.24 percent to close at $76.67. Blueprint Medicines and CStone Pharmaceuticals reported a partnership and license agreement to develop and commercialize Avapritinib, BLU-554 and BLU-667 in Greater China.
  • JinkoSolar Holding Co., Ltd. (NYSE: JKS) fell 9.05 percent to close at $13.77 on Monday after dropping 14.07 percent on Friday.
  • NovoCure Limited (NASDAQ: NVCR) dropped 7.51 percent to close at $29.55. Novocure will present INNOVATE-3 Phase 3 pivotal trial design in recurrent ovarian cancer at the ASCO Annual Meeting 2018.
  • Co-Diagnostics, Inc. (NASDAQ: CODX) fell 7.31 percent to close at $4.44 on Monday after climbing 65.17 percent on Friday.
  • Tactile Systems Technology, Inc. (NASDAQ: TCMD) slipped 7.08 percent to close at $46.87. BTIG Research downgraded Tactile Systems Technology from Buy to Neutral.
  • Viper Energy Partners LP (NASDAQ: VNOM) dropped 6.18 percent to close at $28.52. Stifel Nicolaus downgraded Viper Energy Partners from Buy to Hold.
 

Related Articles (ABAC + ACIU)

View Comments and Join the Discussion!

Posted-In: Losers Movers From YesterdayNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com